Speaker Details


While attending school, Nate Pile, founder and editor of Nate's Notes, met and spent time working for legendary biotech analyst, Jim McCamant, a life-changing experience that inspired him to eventually launch his own newsletter, Nate's Notes, in 1995. Over the past 16 years, Nate's Notes--which is written with "the individual investor" in mind--has quietly become one of the more highly ranked newsletters in the country (as measured by The Hulbert Financial Digest). Mr. Pile lives in Healdsburg, California, and earned a Bachelor's degree in mathematics from U.C. Berkeley. Like Nate's Notes, The Wagmore Advisory Letter - launched in 2014 - takes a very long-term approach to stock selection, with the same bias towards biotech and high-tech stocks. However, unlike Nate's Notes, which uses a thoughtfully modified version of the traditional 'buy and hold' approach to investing, The Wagmore Advisory Letter takes things one step further by also writing covered calls against its stock positions.

Content from Nate Pile

Keyword Image
Disney: A Streaming Future?

After studying the problem for quite some time now, Disney (DIS) has finally made an announcement about how it plans to address the whole “cord cutting” trend that has been going on in the…

Keyword Image
In the Chips: Cirrus and Skyworks

All else being equal, my top stock picks for you this month are Cirrus Logic (CRUS) and Skyworks Solutions (SWKS), notes Nate Pile, growth stock specialist and editor of Nate's Notes. Chips stocks …

Keyword Image
Cliffs Natural and Domestic Steel

There is no doubt that our infrastructure is long overdue for some attention, and this, in turn, will require a lot of steel (which, in turn, will require a lot of iron), asserts Nate Pile, editor o…

Keyword Image
Top Picks 2017: Tekla Life Sciences Investors

My clear choice for a Top Pick for income investing is a closed-end fund that invests in a variety of both public and private companies doing work in the life sciences sector, asserts Nate Pile, ed…

Keyword Image
Top Picks 2017: MannKind

My Top Pick for 2017 is one that has been my favorite high-risk speculation for several years; I will need to eat some crow—from behind the egg on my face—if it doesn't finally gain som…

Keyword Image
Are Better Days Ahead for Mannkind?

Nate Pile takes a look at a long-standing biotech recommendation that has had a very rough few years; nevertheless, the editor of Nate’s Notes continues to believe in the long-term promise of …

Keyword Image
Ranger Targets Bears

In response to requests from a number of subscribers, I have decided to add a “short” ETF to our portfolio, explains Nate Pile, editor of Nate’s Notes. After spending a great dea…

Keyword Image
Top Picks 2016: Tekla Life Sciences Investors

Our Top Pick for income-oriented investors is a closed-end fund that is invested in a number of publicly traded and privately-held companies doing work in the life sciences sector, explains Nate Pi…